30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: Smith & Nephew

4Q14 revenue: $914MM, +4% (U.S. +3%, Other Established Markets flat; Emerging & International +17%)

Knees $235MM, +3% (U.S. flat, ex-U.S. +5%)

Hips $170MM, +2% (U.S. +8%, ex-U.S. -2%)

Sports Medicine $159MM, +8%

Arthroscopic Enabling Technologies $169MM, +2%

Trauma & Extremities $129MM, +3%

  • Continued strong demand for JOURNEY II Total Knee and RT-PLUS knee, which returned to market in Europe
  • Hips driven by VERILAST and direct anterior approach portfolio
  • Syncera “making good progress, encouraged by (3-year) contracts signed and prospective customers”
  • Extremities showing continued strong double-digit growth off a small base, benefiting from HAT-TRICK Lesser Toe Repair launch, investments in salesforce
  • ArthroCare integration on track and largely completed


2014 revenue: $3,298MM, +3 (U.S. +2%, Other Established Markets flat, Emerging & International +17%)

Hips +1%

Knees +2%

Sports Medicine Joint Repair +8%

Arthroscopic Enabling Technologies +1%

Trauma & Extremities +4%

  • Launched cruciate-retaining version of JOURNEY II Knee